Ranbaxy Laboratories Update by Epic Research

Ranbaxy Laboratories has reported net profit of Rs 755.12 crore for the quarter under review as compared to a net loss of Rs 608.80 crore for the quarter ended June 30, 2013. The company’s total income has increased by 49.96% to Rs 2204.39 crore for the quarter under review from Rs 1469.93 crore for the corresponding quarter of the previous year.



Real Time News & Trading Trends Keep Liking #EpicResearch




Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips